Filing Details
- Accession Number:
- 0001209191-13-024741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-07 21:09:58
- Reporting Period:
- 2013-05-06
- Filing Date:
- 2013-05-07
- Accepted Time:
- 2013-05-07 21:09:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1172480 | Santarus Inc | SNTS | Pharmaceutical Preparations (2834) | 330734433 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1279191 | T Gerald Proehl | Santarus, Inc. 3611 Valley Centre Drive #400 San Diego CA 92130 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-06 | 86,603 | $0.88 | 160,740 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-05-06 | 86,603 | $18.73 | 74,137 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2013-05-06 | 86,603 | $0.00 | 86,603 | $0.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2003-05-22 | 2013-05-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 383,570 | Indirect | By Family Trust |
Footnotes
- This exercise and this sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/09/2012.
- The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.35 to $18.99. The reporting person undertakes to provide to Santarus, Inc., any security holder of Santarus, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- Previously held directly by the Reporting Person and were transferred and now held indirectly through Proehl Family Trust, of which the Reporting Person is a trustee.
- 1/60 vest monthly from 5/22/2003.
- Not applicable to this transaction.
Billionaire Hedge Funds
